| Primary |
| Chronic Lymphocytic Leukaemia |
14.5% |
| Prophylaxis |
13.8% |
| B-cell Lymphoma |
11.7% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
11.7% |
| Diffuse Large B-cell Lymphoma |
6.9% |
| Product Used For Unknown Indication |
6.9% |
| Mantle Cell Lymphoma |
6.2% |
| Non-hodgkin's Lymphoma |
6.2% |
| Gastritis |
2.8% |
| Hodgkin's Disease |
2.8% |
| Hypoaesthesia |
2.8% |
| Cerebral Infarction |
2.1% |
| Plasma Cell Myeloma |
2.1% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.4% |
| Hyperuricaemia |
1.4% |
| Infection |
1.4% |
| Lymphoma |
1.4% |
| Multiple Myeloma |
1.4% |
| Pneumonia Aspiration |
1.4% |
| Premedication |
1.4% |
|
| Pyrexia |
11.1% |
| Refusal Of Treatment By Patient |
11.1% |
| Lymphocyte Count Decreased |
8.9% |
| Febrile Neutropenia |
6.7% |
| Pulmonary Embolism |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| C-reactive Protein Increased |
4.4% |
| Cytomegalovirus Infection |
4.4% |
| Headache |
4.4% |
| Hepatitis Toxic |
4.4% |
| Pneumocystis Jiroveci Pneumonia |
4.4% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Squamous Cell Carcinoma Of Skin |
4.4% |
| Vomiting |
4.4% |
| Angiopathy |
2.2% |
| Blood Creatine Phosphokinase Increased |
2.2% |
| Cerebral Haemorrhage |
2.2% |
| Chest Discomfort |
2.2% |
| Confusional State |
2.2% |
| Constipation |
2.2% |
|
| Secondary |
| Prophylaxis |
18.7% |
| Chronic Lymphocytic Leukaemia |
14.1% |
| Product Used For Unknown Indication |
11.1% |
| B-cell Lymphoma |
9.7% |
| Mantle Cell Lymphoma |
9.7% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
8.9% |
| Diffuse Large B-cell Lymphoma |
5.0% |
| Non-hodgkin's Lymphoma |
4.9% |
| Lymphoma |
3.0% |
| Multiple Myeloma |
2.7% |
| Plasma Cell Myeloma |
2.5% |
| Chemotherapy |
2.1% |
| Prophylaxis Of Nausea And Vomiting |
1.5% |
| Cerebral Infarction |
0.9% |
| Periarthritis |
0.9% |
| Breast Cancer Metastatic |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Gastritis |
0.8% |
| Hyperuricaemia |
0.8% |
| Bronchitis |
0.7% |
|
| Pyrexia |
10.2% |
| White Blood Cell Count Decreased |
8.7% |
| Chills |
7.9% |
| Lymphocyte Count Decreased |
7.9% |
| Febrile Neutropenia |
7.1% |
| Lymphopenia |
7.1% |
| Malaise |
7.1% |
| C-reactive Protein Increased |
4.7% |
| Infection |
3.9% |
| Neutropenia |
3.9% |
| Vomiting |
3.9% |
| Cerebral Haemorrhage |
3.1% |
| Cytomegalovirus Infection |
3.1% |
| Flushing |
3.1% |
| Oedema |
3.1% |
| Progressive Multifocal Leukoencephalopathy |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Sepsis |
3.1% |
| Dizziness |
2.4% |
|
| Concomitant |
| Chronic Lymphocytic Leukaemia |
13.8% |
| B-cell Lymphoma |
12.8% |
| Multiple Myeloma |
11.7% |
| Lymphoma |
8.5% |
| Mantle Cell Lymphoma |
7.4% |
| Product Used For Unknown Indication |
5.3% |
| Chemotherapy |
4.3% |
| Chronic Lymphocytic Leukaemia Recurrent |
4.3% |
| Non-hodgkin's Lymphoma |
4.3% |
| Paraneoplastic Pemphigus |
4.3% |
| Prophylaxis |
4.3% |
| Rash |
3.2% |
| Anaemia Of Malignant Disease |
2.1% |
| Antibiotic Therapy |
2.1% |
| Atrial Fibrillation |
2.1% |
| Diffuse Large B-cell Lymphoma |
2.1% |
| Hypertension |
2.1% |
| Mantle Cell Lymphoma Refractory |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Age-related Macular Degeneration |
1.1% |
|
| Progressive Multifocal Leukoencephalopathy |
16.0% |
| Squamous Cell Carcinoma |
8.0% |
| Thrombocytopenia |
8.0% |
| Atrial Hypertrophy |
4.0% |
| Cytolytic Hepatitis |
4.0% |
| Cytomegalovirus Infection |
4.0% |
| Diffuse Large B-cell Lymphoma |
4.0% |
| Drug Interaction |
4.0% |
| Fatigue |
4.0% |
| Grand Mal Convulsion |
4.0% |
| Haematuria |
4.0% |
| Haemoglobin Decreased |
4.0% |
| Injection Site Pain |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Lymphocyte Count Decreased |
4.0% |
| Multiple Myeloma |
4.0% |
| Musculoskeletal Pain |
4.0% |
| Neutropenia |
4.0% |
| Oesophagitis |
4.0% |
| Pleural Effusion |
4.0% |
|
